Pancreatic Exocrine Insufficiency -> Malabsorption (Ultra-Short Note)

The Core Chain (Chronic Pancreatitis)

Repeated inflammation
      ↓
Acinar cell destruction + fibrotic replacement of parenchyma
      ↓
↓↓ Lipase  |  ↓↓ Proteases  |  ↓ Amylase
  (most sensitive)
      ↓
Undigested fat / protein / carbs pass into colon
      ↓
Steatorrhoea + Azotorrhoea + Osmotic diarrhoea

Why Fat is Affected First and Worst

• Lipase is the most vulnerable enzyme - it degrades faster and has no backup salvage pathway (bile salts alone cannot break down fat without lipase).
• Proteases have partial backup from intestinal brush border peptidases, and amylase has salivary backup - so protein and carb digestion are relatively preserved longer.
• Result: steatorrhoea (bulky, oily, foul-smelling stools) is the hallmark.

Secondary Consequences

One Extra Point: The Bicarbonate Problem

Clinical diagnosis only - no single test is confirmatory; Berlin criteria (bilateral opacities + PaO2/FiO2 ratio + non-cardiac cause within 1 week) have ~84% sensitivity, ~51% specificity vs autopsy gold standard - it over-diagnoses in clinical practice because bilateral opacities and hypoxia overlap heavily with cardiogenic oedema and pneumonia.

No single test diagnoses DIC - it's a pattern diagnosis (low platelets + elevated PT/aPTT + low fibrinogen + high D-dimer + high FDP together); the ISTH overt-DIC scoring system has ~93% sensitivity and ~98% specificity in established cases, but early/non-overt DIC is frequently missed because tests can be normal or borderline.

Repeated inflammation → acinar fibrosis → enzymes drop below 10% of normal → lipase fails first (no backup) → fat malabsorption = steatorrhoea (hallmark); proteins/carbs spared longer due to brush-border & salivary backups. Ductal fibrosis also kills bicarbonate secretion → acidic duodenum → inactivates remaining enzymes → double hit. Late: islet loss → diabetes.

🔑 Fibrosis kills acini → lipase gone first → fat can't be digested → steatorrhoea; threshold = <10% enzyme output.

Trousseau Syndrome (Migratory Thrombophlebitis)

The Core Mechanism

Tumour cells (esp. mucin-secreting adenocarcinoma)
        ↓
Release tissue factor, procoagulant mucin,
microparticles + trigger NETosis (neutrophil
extracellular traps)
        ↓
Activates extrinsic coagulation pathway
        ↓
Systemic thrombin generation
        ↓
Clot forms in one vein → dissolves → reappears elsewhere
= "migratory" thrombophlebitis

Cancers Most Associated

Clinical Spectrum (Modern Definition)

• Superficial migratory thrombophlebitis (original)
• Deep vein thrombosis - often unusual sites (upper limbs, cerebral venous sinuses, portal/mesenteric veins)
• Pulmonary embolism
• Nonbacterial thrombotic (marantic) endocarditis
• Overt DIC in disseminated cancer

Key Clinical Pearl

Spontaneous, unexplained, or recurrent VTE in an otherwise healthy person = screen for occult malignancy, especially pancreatic cancer. Trousseau syndrome can precede cancer diagnosis by months.

Sticky Note Version

Tumour (esp. pancreatic/gastric adenocarcinoma) releases procoagulants (tissue factor + mucin) → systemic hypercoagulability → clots that appear, dissolve, and migrate to new veins. Classic paraneoplastic sign - recurrent unexplained DVT/PE = rule out occult cancer. Treat: LMWH (first-line) + treat underlying cancer.

• The thrombosis is not caused by the tumour directly blocking a vein (that would just be local compression/invasion)
• It is caused by soluble factors - tissue factor, procoagulant mucin, microparticles, cytokines - secreted by the tumour into the circulation
• These factors act at a distance, causing clots in veins nowhere near the tumour
• The clots migrate - appearing in the arm today, the leg next week - which only makes sense if it is a systemic circulating stimulus, not a local mechanical one

"Paraneoplastic" = tumour causes harm remotely via secreted substances, not by physical invasion. Trousseau = tumour secretes procoagulants → systemic hypercoagulability → clots anywhere. Remote + humoral = paraneoplastic. ✓

Cholestyramine → Cholesterol Gallstones: Full Physiology

Step 1 - Normal Bile Acid Physiology First

Step 2 - What Cholestyramine Does

• Bound bile acids cannot be reabsorbed in the terminal ileum
• They are excreted in faeces
• The bile acid pool shrinks
• Less bile acid returns to the liver via portal circulation

Step 3 - The Liver's Response (Why It Works as a Lipid-Lowering Drug)

• FXR suppression is lifted → CYP7A1 is upregulated
• The liver converts more cholesterol into bile acids to replenish the pool
• Intrahepatic cholesterol falls
• The liver upregulates LDL receptors on its surface to pull more LDL-cholesterol from blood
• Serum LDL drops ✓

Step 4 - Why Gallstones Form (Your Question)

Cholestyramine binds bile acids in gut
          ↓
Less bile acid reabsorbed from ileum
          ↓
Liver upregulates CYP7A1 → converts MORE cholesterol → bile acids
(to replenish the shrunken pool)
          ↓
BUT: the newly synthesised bile acids are also being
continuously bound and excreted by the drug
          ↓
NET RESULT: Bile acid pool in bile REMAINS LOW/DEPLETED
          ↓
In the gallbladder, bile now has:
  - ↓ Bile acids (less solubilising capacity)
  - ↓ Lecithin (follows bile acids proportionally)
  - Normal or ↑ Cholesterol secretion (liver still secretes cholesterol)
          ↓
LITHOGENIC BILE = Cholesterol supersaturation
(more cholesterol than bile acids + lecithin can hold in micelles)
          ↓
Cholesterol precipitates → nucleation → crystal formation
          ↓
CHOLESTEROL GALLSTONES

The Key Concept: The Cholesterol Saturation Index (CSI)

CSI = Cholesterol secreted / (Bile acids + Lecithin solubilising capacity)

• Normal bile: CSI < 1 (cholesterol fully dissolved in micelles)
• Lithogenic bile: CSI > 1 (cholesterol supersaturated, starts to crystallise)

Sticky Note Version

Drug binds bile acids in gut → ↓ ileal reabsorption → ↓ bile acid pool in bile → cholesterol has less bile acid/lecithin to dissolve in → bile becomes supersaturated with cholesterol (CSI >1) → precipitation → cholesterol gallstones. The lipid-lowering benefit (LDL receptor upregulation) and the gallstone risk are two sides of the same mechanism.

Why Oil Won't Dissolve in Water (and How Bile Fixes It)

The Basic Problem: "Like Dissolves Like"

• Water molecules exclude the oil because they'd rather stick to each other
• The oil gets pushed together into a droplet - that's why it floats on top as one blob
• This is called the hydrophobic effect - water is not "repelling" oil aggressively, it's just that water-water bonds are far more favourable

Now Imagine the Bile Acid Molecule

[ Hydrophilic face ]   ← OH groups, charged side chains
   ████████████
[ Hydrophobic face ]   ← steroid ring, methyl groups (greasy)

How the Micelle Forms - Naturally

1. The greasy tails/faces of bile acids and lecithin are uncomfortable in water - they instinctively cluster away from water
2. The cholesterol molecule (pure oil) gets tucked into the centre of this cluster - surrounded by the greasy faces
3. The water-loving faces of bile acids and lecithin face outward toward the water
4. The result is a tiny sphere - a micelle - that looks like this from the side:

        Water (outside)
   ~~~~~~~~~~~~~~~~~~~~~
   ~  [+]  [+]  [+]  ~      ← hydrophilic heads facing water
   ~   |    |    |   ~
   ~  ~~~[CHOL]~~~  ~      ← cholesterol hidden in greasy core
   ~   |    |    |   ~
   ~  [+]  [+]  [+]  ~      ← hydrophilic heads facing water
   ~~~~~~~~~~~~~~~~~~~~~
        Water (outside)

The Glass of Water Analogy - Completed

Why Both Bile Acids AND Lecithin Are Needed

• Bile acids alone can form simple micelles but can only hold a small amount of cholesterol
• Lecithin alone forms bilayers (like cell membranes) - not great for solubilising cholesterol in water
• Together they form mixed micelles - far larger and more stable, capable of holding much more cholesterol in solution
• This is why the ratio matters: if bile acids fall (cholestyramine) or lecithin falls, the micelle capacity drops and cholesterol exceeds what can be held → precipitates → stone

One-Line Summary

Bile acids and lecithin are biological soap - they wrap their greasy sides around cholesterol and point their water-friendly sides outward, creating a micelle that tricks water into accepting oil. Remove the soap → oil crashes out of solution → stone.

The Full Bilirubin Pathway First

RBC breakdown → Haem → Unconjugated bilirubin (UCB)
                              ↓
                    Bound to albumin in blood
                    (lipid soluble, NOT water soluble)
                    (CANNOT pass into urine)
                              ↓
                    Liver conjugates it → Conjugated bilirubin (CB)
                    (water soluble)
                              ↓
                    Secreted into bile → Duodenum
                              ↓
                    Gut bacteria convert CB → Urobilinogen
                              ↓
              ┌───────────────┴───────────────┐
              ↓                               ↓
       ~80% stays in gut            ~20% reabsorbed (portal)
       oxidised → Stercobilin              ↓
       (brown stool colour)        Liver re-excretes most
                                   back into bile
                                          ↓
                                   Small amount escapes
                                   into systemic circulation
                                          ↓
                                   Filtered by kidney → Urinary urobilinogen
                                   (gives urine pale yellow tint - NORMAL)

Now Your Three Scenarios - Corrected Precisely

Scenario 1 - Pre-hepatic Jaundice (e.g. Haemolysis)

• Massive RBC breakdown → huge load of UCB
• UCB is albumin-bound, lipid-soluble → cannot enter urine → urine NOT dark from bilirubin ✓ (you are correct)
• BUT - this huge UCB load arrives at the liver, gets conjugated, large amount of CB dumped into bile → more CB reaches the gut → more urobilinogen produced
• More urobilinogen reabsorbed → more escapes kidney → ↑↑ urinary urobilinogen ✓
• Stool is also very dark (excess stercobilin)

Scenario 2 - Hepatic Jaundice (e.g. Viral Hepatitis)

• Liver cells are damaged → they conjugate less efficiently → some UCB builds up
• But also - damaged hepatocytes leak CB back into blood (regurgitation)
• CB is water-soluble → passes freely into urine → bilirubinuria → dark urine ✓

• Damaged liver cells cannot re-excrete the reabsorbed urobilinogen back into bile properly
• So urobilinogen builds up in blood and spills into urine → urinary urobilinogen can be elevated early
• But as hepatitis worsens → less CB reaches the gut (damaged hepatocytes not secreting bile properly) → less urobilinogen produced → urinary urobilinogen may actually decrease or normalise

Scenario 3 - Post-hepatic / Obstructive Jaundice (e.g. Stone, Cancer)

• Bile duct blocked → CB cannot reach the gut
• No CB in gut → no urobilinogen produced → urinary urobilinogen = ZERO/absent
• CB backs up into blood → water-soluble → spills into urine → bilirubinuria → dark urine
• Stool is pale/clay-coloured (no stercobilin)
• Urine is dark (CB) but urobilinogen is absent on dipstick

Your "Proxy" Concept - Refined

Urinary urobilinogen = proxy for gut delivery of conjugated bilirubin AND intact hepatic re-excretion function

The Topper Table

Cheap Trick to Remember

"No bile in gut = no urobilinogen in urine"

• Obstruction → zero urobilinogen (gut gets no CB)
• Haemolysis → high urobilinogen (gut flooded with CB)
• Hepatitis → bilirubin IN urine is the key finding (CB leaks back into blood)

🔑 UCB = fat-soluble = stays in blood, never in urine. CB = water-soluble = leaks into urine. Urobilinogen = tells you how much CB reached the gut.